Pharmacy

In the U.S., 168 healthcare organizations have received accreditation for immune effector cell therapy from the Foundation for the Accreditation of Cellular Therapy. An additional seven received standalone immune effector cell therapy accreditation, meaning the facilities operate outside of a…

A series of recent FDA safety actions, drug recalls, label updates and court rulings across pharmacy carry operational implications for pharmacy leaders. The cases span product categories — from a drug linked to fatal liver injuries to contaminated children’s ibuprofen…

Amazon Pharmacy has launched same-day and next-day prescription delivery across hundreds of Ohio cities and towns with the opening of two Same-Day Delivery sites in Lockbourne and Middleburg Heights. The company said the expansion comes as 79 pharmacies have closed…

Gainesville-based University of Florida College of Pharmacy has launched a new AI hub designed to centralize the college’s AI research, clinical collaboration and educational initiatives. The hub’s flagship initiative is PharmAIcist, an AI platform designed to integrate with EHRs and…

Hospitals and health systems nationwide are seeking pharmacy leaders as the role expands amid drug pricing pressure, supply chain constraints and growing 340B oversight. Many organizations have sharpened their focus on pharmacy as a strategic lever — elevating its role…

The Civica Foundation has received a $3.2 million grant to launch a program aimed at expanding access to generic medications for rural hospitals in nine states. The Civica Rural Hospital Program will support rural and critical access hospitals in Hawaii,…

Virginia Governor Abigail Spanberger has vetoed two bills that would have created a prescription drug pricing system in the state, arguing similar models in other states have failed to lower drug costs. The legislation, House Bill 483 and Senate Bill…

States are advancing legislation to restrict how pharmacy benefit managers operate. In doing so, they are targeting practices such as steering patients to PBM-owned pharmacies, spread pricing, and opaque rebate arrangements that critics say inflate drug costs while squeezing independent…

Medicare beneficiaries enrolled in Part D plans offered by vertically integrated insurers paid lower monthly premiums but higher out-of-pocket drug costs compared to enrollees in other plans, according to a May 19 analysis from the HHS Office of Inspector General. …

Drug costs, and specialty drug costs in particular, keep rising faster than inflation, testing hospitals’ capacity to continue to treat patients with chronic, rare and orphan conditions. Partnering with an experienced specialty pharmacy such as Lumicera can help health systems…